← FDA DRUG APPROVALS

FDA ANDA · ANDA078560

EZETIMIBE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA078560
TYPE
ANDA
ORIGINAL APPROVAL
2015-06-26
LATEST ACTION
2024-06-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

EZETIMIBEPrescription
EZETIMIBE 10MG · TABLET · ORAL

Approval history

2024-06-03Labeling · Supplement 11 · standardAP
2024-02-16Labeling · Supplement 8 · standardAP
2015-06-26OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →